Astrana Health (ASTH) Expected to Announce Earnings on Tuesday

Astrana Health (NASDAQ:ASTH) is projected to announce its earnings results before the market opens on Tuesday, February 25th. Analysts expect the company to announce earnings of $0.22 per share and revenue of $617.24 million for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

Astrana Health Stock Down 4.6 %

Shares of NASDAQ ASTH opened at $35.68 on Friday. The firm has a market cap of $2.01 billion, a PE ratio of 27.45, a P/E/G ratio of 1.44 and a beta of 1.20. Astrana Health has a 12-month low of $29.08 and a 12-month high of $63.20. The company’s fifty day simple moving average is $35.06 and its 200 day simple moving average is $44.97. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60.

Analysts Set New Price Targets

Several research analysts recently issued reports on ASTH shares. Stifel Nicolaus cut their target price on shares of Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a research note on Thursday. Robert W. Baird increased their target price on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th. Truist Financial dropped their price objective on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating on the stock in a research note on Monday, January 13th. Finally, Macquarie raised shares of Astrana Health to a “hold” rating in a research note on Monday, December 16th. Two analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Astrana Health has an average rating of “Moderate Buy” and an average price target of $63.00.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.